# Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study

> **NCT00344487** · NA · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 3 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Lopinavir/Ritonavir

## Key facts

- **NCT ID:** NCT00344487
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2009-05
- **Final completion:** 2009-09
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Inability to enroll subjects.
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344487, "Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00344487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*